Timothy Robert Henrichs net worth and biography

Timothy Henrichs Biography and Net Worth

CFO of NeurAxis

Mr. Henrichs brings over 20 years of global leadership experience across several industries, including healthcare, home improvement, retail, software, and education. Most recently, Mr. Henrichs served as a member of the NeurAxis Board since August 8, 2023, and the Chief Financial Officer of Renovo Home Partners since 2022. He also served as the Executive Vice President and Chief Financial Officer of Follett Corporation from 2008 to 2022 and Global Controller of General Electric Company's Healthcare Clinical Systems division responsible for the manufacture and distribution of medical devices to the ultrasound, patient monitoring, and anesthesiology markets from 2005 to 2008 in addition to leadership positions at Federal Signal Corporation and Ernst & Young LLP. Mr. Henrichs earned his bachelor's degree in accounting from the University of Notre Dame and is a Certified Public Accountant with an inactive license in the State of Illinois.

What is Timothy Robert Henrichs' net worth?: The estimated net worth of Timothy Robert Henrichs is at least $59.36 thousand as of April 1st, 2026. Mr. Henrichs owns 7,593 shares of NeurAxis stock worth more than $59,362 as of September 17th. This net worth approximation does not reflect any other assets that Mr. Henrichs may own. Learn More about Timothy Robert Henrichs' net worth.
How do I contact Timothy Robert Henrichs?: The corporate mailing address for Mr. Henrichs and other NeurAxis executives is 11611 N. Meridian ST, Suite 330, Carmel, IN, 46032. NeurAxis can also be reached via phone at (812) 689-0791 and via email at [email protected]. Learn More on Timothy Robert Henrichs' contact information.
Has Timothy Robert Henrichs been buying or selling shares of NeurAxis?: Timothy Robert Henrichs has not been actively trading shares of NeurAxis within the last three months. Most recently, on Wednesday, April 1st, Timothy Robert Henrichs bought 7,593 shares of NeurAxis stock. The stock was acquired at an average cost of $1.96 per share, with a total value of $14,882.28. Following the completion of the transaction, the chief financial officer now directly owns 7,593 shares of the company's stock, valued at $14,882.28. Learn More on Timothy Robert Henrichs' trading history.
Who are NeurAxis' active insiders?: NeurAxis' insider roster includes Gil Aharon (Director), Brian Carrico (CEO), Thomas Carrico (Insider), and Timothy Henrichs (CFO). Learn More on NeurAxis' active insiders.
Are insiders buying or selling shares of NeurAxis?: During the last twelve months, NeurAxis insiders bought shares 4 times. They purchased a total of 302,458 shares worth more than $1,039,192.96. The most recent insider tranaction occured on April, 1st when CFO Timothy Robert Henrichs bought 7,593 shares worth more than $14,882.28. Insiders at NeurAxis own 21.1% of the company. Learn More about insider trades at NeurAxis.
Information on this page was last updated on 4/1/2026.

Timothy Robert Henrichs Insider Trading History at NeurAxis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
4/1/2026	Buy	7,593	$1.96	$14,882.28	7,593

Timothy Robert Henrichs Buying and Selling Activity at NeurAxis

NeurAxis Company Overview

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Today's Range

Now: $7.66

$7.25

$8.06

50 Day Range

MA: $6.41

$5.69

$7.21

2 Week Range

Now: $7.66

$2.21

$9.33

Volume

496,864 shs

Average Volume

135,850 shs

Market Capitalization

$96.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47